Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | ERN1 | O75460 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.36 |
| ▸ | TYR | P14679 | 2/20 | 0.35 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.35 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL606252 | 0.83 | SRC (0.50) | SRCALDH1A1ERN1KDM4EGAA | |
| SCHEMBL16494601 | 0.80 | SRC (0.47) | SRCALDH1A1ERN1KDM4EGAA | |
| SCHEMBL9806957 | 0.79 | SRC (0.75) | SRCALDH1A1ERN1KDM4EGAA | |
| SCHEMBL28765524 | 0.78 | SRC (0.50) | SRCALDH1A1ERN1KDM4EGAA | |
| SCHEMBL5527536 | 0.78 | TYR (0.40) | ERN1TYRTRIM24TRIM33 | |
| SCHEMBL28063870 | 0.78 | EGFR (0.47) | SRCERN1KDM4E | |
| SCHEMBL13967778 | 0.77 | SRC (0.45) | SRCALDH1A1ERN1KDM4EGAA | |
| SCHEMBL17749073 | 0.77 | SRC (0.45) | SRCALDH1A1ERN1KDM4EGAA | |
| SCHEMBL15609817 | 0.77 | EGFR (0.55) | SRCALDH1A1LMNAHPGD | |
| SCHEMBL15609816 | 0.77 | EGFR (0.55) | SRCALDH1A1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11273168-B2 | Methods of treating anxiety by administering a substituted quinolone | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2022-03-15 | — | — | US | disclosed |
| EP-1890992-B1 | AN ENRICHMENT PROCESS USING COMPOUNDS USEFUL IN A POLYESTER PROCESS | GRUPO PETROTEMEX SA DE CV (MX) | 2019-10-23 | — | — | EP | disclosed |
| EP-1888498-B1 | A PROCESS TO PRODUCE AN ENRICHMENT FEED | GRUPO PETROTEMEX SA DE CV (MX) | 2019-06-26 | — | — | EP | disclosed |
| EP-1888497-B1 | A PROCESS TO PRODUCE AN ENRICHED COMPOSITION THROUGH THE USE OF A CATALYST REMOVAL ZONE AND AN ENRICHMENT ZONE | GRUPO PETROTEMEX SA DE CV (MX) | 2019-04-17 | — | — | EP | disclosed |
| EP-2066612-B1 | A PROCESS TO PRODUCE AN ENRICHMENT FEED | GRUPO PETROTEMEX SA DE CV (MX) | 2018-08-01 | — | — | EP | disclosed |
| US-10029973-B2 | Optimized liquid-phase oxidation | GROPO PETROTEMEX, S.A. DE C.V. (MX) | 2018-07-24 | — | — | US | disclosed |
| US-20180072648-A1 | OPTIMIZED LIQUID-PHASE OXIDATION | GRUPO PETROTEMEX, S.A. DE C.V. (MX) | 2018-03-15 | — | — | US | disclosed |
| EP-2316566-B1 | Bubble column reactor for gas-liquid exchange reactions | GRUPO PETROTEMEX SA DE CV (MX) | 2017-11-22 | — | — | EP | disclosed |
| EP-1791800-B1 | OPTIMIZED LIQUID-PHASE OXIDATION | GRUPO PETROTEMEX SA DE CV (MX) | 2017-11-01 | — | — | EP | disclosed |
| EP-1881953-B1 | A PROCESS TO PRODUCE AN ENRICHED CARBOXYLIC ACID COMPOSITION | GRUPO PETROTEMEX SA DE CV (MX) | 2017-10-25 | — | — | EP | disclosed |
| US-20060047151-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047155-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047149-A1 | Optimized liquid-phase oxidation | GRUPO PETROTEMEX, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047157-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047154-A1 | Optimized liquid-phase oxidation | GRUPO PETROTEMEX, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047142-A1 | Optimized liquid-phase oxidation | GRUPO PETROTEMEX, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047161-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047143-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047163-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047147-A1 | Carried out in a bubble column reactor that provides for a highly efficient reaction at relatively low temperatures; oxidizing p-xylene to form terephthalic acid that can be purified more easily that if higher temperatures were required. | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11273168-B2 | Methods of treating anxiety by administering a substituted quinolone | CRH, MC2R, HTR3C | SRC 3281/4885ALDH1A1 1739/4885ERN1 3640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.